Evidence map›Paper›PMID 34839363›Full record

SynthesisNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2022

Systematic review of structural and functional neuroimaging studies of cannabis use in adolescence and emerging adulthood: evidence from 90 studies and 9441 participants.

Sarah D Lichenstein, Nick Manco, Lora M Cope, Leslie Egbo, Kathleen A Garrison, Jillian Hardee, Ansel T Hillmer, Kristen Reeder, Elisa F Stern, Patrick Worhunsky and 1 more

Open access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 55 citations in OpenAlex.

  1. [Effectiveness of a cannabis prevention program in school: results of a randomized prospective study].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2024
    Trial
  2. The role of subcortical brain tissue iron as an indicator of dopamine neurophysiology in adolescent cannabis use.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  3. Article
  4. Altered reward-related resting-state network properties in adolescent cannabis use and depression.Progress in neuro-psychopharmacology & biological psychiatry · 2026
    Article
  5. Article
  6. Independent brain cortical signatures of risk for adolescent cannabis use and consequences of such use are moderated by sex.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Chronic ΔNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Cells and Molecules Underpinning Cannabis-Related Variations in Cortical Thickness during Adolescence.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  18. Exploring causal mechanisms of psychosis risk.Neuroscience and biobehavioral reviews · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Sarah D LichensteinDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA. sarah.lichenstein@yale.edu.ORCID http://orcid.org/0000-0002-2978-991X
Nick MancoMedical University of South Carolina, Charleston, SC, USA.
Lora M CopeDepartment of Psychiatry and Addiction Center, University of Michigan, Ann Arbor, MI, USA.
Leslie EgboNeuroscience and Behavior Program, Wesleyan University, Middletown, CT, USA.
Kathleen A GarrisonDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-7582-1351
Jillian HardeeDepartment of Psychiatry and Addiction Center, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0001-8230-3045
Ansel T HillmerDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-8105-1381
Kristen ReederDepartment of Internal Medicine, East Carolina University/Vidant Medical Center, Greenville, NC, USA.ORCID http://orcid.org/0000-0002-7083-7442
Elisa F SternDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO, USA.
Patrick WorhunskyDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-9629-1428
Sarah W YipDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Yale University · USUniversity of Michigan · USMedical University of South Carolina · USUniversity of Colorado Boulder · USVidant Medical Center · USWesleyan University · US

Funding

Michigan Institute for Clinical and Health Research (MICHR)UL1TR002240 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, JULIE C, MASHOUR, GEORGE ALEXANDER · 2017 to 2022
$54.9M
Neuroimaging Sciences Training ProgramT32DA022975 · NIDA · YALE UNIVERSITY · PI Graeme F Mason, Rajita Sinha · 2007 to 2026
$5.7M
The impact of e-cigarette advertising and warning labels on e-cigarette use behavior in adolescentsR01DA046334 · NIDA · YALE UNIVERSITY · PI GARRISON, KATHLEEN A. · 2019 to 2021
$1.3M
Connectome-based neuromarkers of problem cannabis useK08DA051667 · NIDA · YALE UNIVERSITY · PI LICHENSTEIN, SARAH D. · 2020 to 2024
$959k
Neural mechanisms of galantamine treatment for cocaine dependenceK01DA039299 · NIDA · YALE UNIVERSITY · PI YIP, SARAH · 2016 to 2020
$905k
Multimodal Neuroimaging of Alcohol Withdrawal: The Role of Glutamate in Neural ReorganizationK01AA024788 · NIAAA · YALE UNIVERSITY · PI HILLMER, ANSEL · 2017 to 2021
$894k
Multi-method signature of risk for compulsive substance use: Human translation of the incentive-sensitization modelK01DA044270 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COPE, LORA M. · 2019 to 2023
$835k
Sex differences in the neural mechanisms of brief interventions for binge drinkingK01AA024804 · NIAAA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HARDEE, JILLIAN ELIZABETH · 2016 to 2020
$830k
Aging Heart and Vessels (International Conference)R13AG024788 · NIA · INTERNATIONAL SOCIETY FOR HEART RESEARCH · PI DOWNEY, JAMES M · 2004 to 2004
$30k
NCATS NIH HHS UL1 TR002240NIAAA NIH HHS K01 AA024788NIAAA NIH HHS K01 AA024804NIDA NIH HHS K01 DA039299NIDA NIH HHS K01 DA044270NIDA NIH HHS K08 DA051667NIDA NIH HHS R01 DA046334NIDA NIH HHS T32 DA022975
6 · The paper itself

Abstract

Cannabis use peaks in adolescence, and adolescents may be more vulnerable to the neural effects of cannabis and cannabis-related harms due to ongoing brain development during this period. In light of ongoing cannabis policy changes, increased availability, reduced perceptions of harm, heightened interest in medicinal applications of cannabis, and drastic increases in cannabis potency, it is essential to establish an understanding of cannabis effects on the developing adolescent brain. This systematic review aims to: (1) synthesize extant literature on functional and structural neural alterations associated with cannabis use during adolescence and emerging adulthood; (2) identify gaps in the literature that critically impede our ability to accurately assess the effect of cannabis on adolescent brain function and development; and (3) provide recommendations for future research to bridge these gaps and elucidate the mechanisms underlying cannabis-related harms in adolescence and emerging adulthood, with the long-term goal of facilitating the development of improved prevention, early intervention, and treatment approaches targeting adolescent cannabis users (CU). Based on a systematic search of Medline and PsycInfo and other non-systematic sources, we identified 90 studies including 9441 adolescents and emerging adults (n = 3924 CU, n = 5517 non-CU), which provide preliminary evidence for functional and structural alterations in frontoparietal, frontolimbic, frontostriatal, and cerebellar regions among adolescent cannabis users. Larger, more rigorous studies are essential to reconcile divergent results, assess potential moderators of cannabis effects on the developing brain, disentangle risk factors for use from consequences of exposure, and elucidate the extent to which cannabis effects are reversible with abstinence. Guidelines for conducting this work are provided.

Indexed as

Adolescent BehaviorCannabisAdolescentAdultBrainFunctional NeuroimagingHumans

Identifiers

PMID34839363
PMCPMC8938408
OpenAlexW3216584332

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.